119.3K
Downloads
255
Episodes
Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization.
Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist consulting firms. Our host Raman is an entrepreneur, investor, bestselling author, speaker and long time industry insider.
Episodes
Friday Oct 16, 2020
Friday Oct 16, 2020
In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Dexter Tjoa, Chief Executive Officer at Tjoapack, Erik Haeffler, VP Manufacturing Services & Head of Sustainability at Recipharm AB, John Ross, President at Mayne Pharma and Metrics Contract Services, and Mark Emalfarb, CEO, Board Member and Founder at Dyadic International, Inc.
During this discussion we will explore two angles to driving efficiency, diversification vs. development of specialism. Emerging trends include the move to manufacture multiple technologies under one roof, at the other end of the scale we see companies staying true to original areas of expertise in order to refine and grow.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.
No comments yet. Be the first to say something!